Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

Ontology Browser
Term:
Parent Terms Term With Siblings Child Terms
2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline 
2-methyl-6-(phenylethynyl)pyridine 
5-aza-2′-deoxycytidine 
5-bromo-2'-deoxyuridine 
5-fluorouracil 
adrenergic antagonist +  
afatinib 
Allyl isothiocyanate 
almorexant 
angiotensin II receptor antagonist +   
bardoxolone 
bleomycin 
BTB14431 
caffeine +  
Capsazepine 
cenicriviroc 
cholinergic antagonist +   
cimetidine 
cisplatin +  
clodronic acid +  
clozapine 
curcumin 
cyclophosphamide 
diallyl trisulfide 
diethylstilbestrol  
diphenhydramine 
doxorubicin +  
emodin 
endothelin receptor antagonist +  
enrofloxacin +  
epigallocatechin-3-gallate 
everolimus 
floxuridine +  
flutamide 
gefitinib 
gingerol 
GSK-812 
hydroxyzine 
icatibant 
ionotropic glutamate receptor antagonist +  
isoliensinine 
lapatinib 
letrozole 
luteolin 
megestrol 
metiamide 
mineralocorticoid receptor antagonist +  
mitogen-activated protein kinase inhibitor +  
MK-3207 
nintedanib 
NMDA receptor antagonist +  
olanzapine 
oxaliplatin 
paclitaxel 
pentolinium  
perhexiline maleate 
phloretin 
phosphoramidon 
Pkc-IN-1 +  
puromycin 
sanguinarine 
SB525334 
semaxanib 
sorafenib 
spiroplatin 
sunitinib 
A condition in which the main influencing factor is sunitinib, an antineoplastic agent which acts as a receptor tyrosine kinase inhibitor and an antagonist for multiple platelet-derived growth factor and vascular endothelial growth factor receptors. Sunitinib is used as a chemotherapy agent in the treatment of renal cell carcinoma and gastrointestinal stromal tumor.
taurolidine 
telcagepant 
ticlopidine +  
tolvaptan +  
troglitazone 
UNC0638 
urethane 
vinblastine 
Y-27632 
zafirlukast 

Synonyms
Related Synonyms: Sutent ;   sunitinibum
Xrefs: CHEBI:38940
Definition Sources: https://en.wikipedia.org/wiki/Sunitinib "Wikipedia" "Wikipedia"

paths to the root